Sector:
Biotech
Life Science
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
About
Vima Therapeutics is a clinical-stage biotechnology company pioneering a new era in the treatment of dystonia and related movement disorders by advancing an oral therapy designed to help patients with dystonia improve control of their movement by targeting the root cause of the disease. Founded and incubated at Atlas Venture by physicians and scientists with deep expertise in movement disorders, Vima is advancing VIM0423 – a potential first-in-class oral therapy – in a Phase 1 clinical trial, with plans to initiate Phase 2 by the fourth quarter of 2025. Vima Therapeutics is headquartered in Cambridge, Massachusetts.
YouTube
Team
